A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma

John D. Hainsworth, Edward R. Arrowsmith, Michael McCleod, Eric D. Hsi, Oday Hamid, Peipei Shi, Boris K. Lin, Luis E. Fayad

Research output: Contribution to journalLetterpeer-review

22 Scopus citations
Original languageEnglish (US)
Pages (from-to)216-218
Number of pages3
JournalLeukemia and Lymphoma
Volume57
Issue number1
DOIs
StatePublished - Jan 2 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

MD Anderson CCSG core facilities

  • Clinical and Translational Research Center

Cite this